107 related articles for article (PubMed ID: 9031104)
1. Inactivation of the p15INK4B and p16INK4 genes in hematologic malignancies.
Heyman M; Einhorn S
Leuk Lymphoma; 1996 Oct; 23(3-4):235-45. PubMed ID: 9031104
[TBL] [Abstract][Full Text] [Related]
2. p16INK4/p15INK4B gene inactivation is a frequent event in malignant T-cell lines.
Borgonovo Brandter L; Heyman M; Rasool O; Liu Y; Grandér D; Einhorn S
Eur J Haematol; 1996 May; 56(5):313-8. PubMed ID: 8641406
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4B) in human ovarian carcinoma cell lines.
Yaginuma Y; Hayashi H; Kawai K; Kurakane T; Saitoh Y; Kitamura S; Sengoku K; Ishikawa M
Exp Cell Res; 1997 Jun; 233(2):233-9. PubMed ID: 9194486
[TBL] [Abstract][Full Text] [Related]
4. Alterations of the p15, p16,and p18 genes in osteosarcoma.
Miller CW; Aslo A; Campbell MJ; Kawamata N; Lampkin BC; Koeffler HP
Cancer Genet Cytogenet; 1996 Feb; 86(2):136-42. PubMed ID: 8603340
[TBL] [Abstract][Full Text] [Related]
5. Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers.
Yoshida S; Todoroki T; Ichikawa Y; Hanai S; Suzuki H; Hori M; Fukao K; Miwa M; Uchida K
Cancer Res; 1995 Jul; 55(13):2756-60. PubMed ID: 7796400
[TBL] [Abstract][Full Text] [Related]
6. Association of rat p15INK4B/p16INK4 deletions with monosomy 5 in kidney epithelial cell lines but not primary renal tumors.
Knapek DF; Serrano M; Beach D; Trono D; Walker CL
Cancer Res; 1995 Apr; 55(8):1607-12. PubMed ID: 7712460
[TBL] [Abstract][Full Text] [Related]
7. p16ink4a gene and hematological malignancies.
Quesnel B; Preudhomme C; Fenaux P
Leuk Lymphoma; 1996 Jun; 22(1-2):11-24. PubMed ID: 8724524
[TBL] [Abstract][Full Text] [Related]
8. Homozygous loss of the p15INK4B gene (and not the p16INK4 gene) during tumor progression in a sporadic melanoma patient.
Glendening JM; Flores JF; Walker GJ; Stone S; Albino AP; Fountain JW
Cancer Res; 1995 Dec; 55(23):5531-5. PubMed ID: 7585628
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies.
Hangaishi A; Ogawa S; Imamura N; Miyawaki S; Miura Y; Uike N; Shimazaki C; Emi N; Takeyama K; Hirosawa S; Kamada N; Kobayashi Y; Takemoto Y; Kitani T; Toyama K; Ohtake S; Yazaki Y; Ueda R; Hirai H
Blood; 1996 Jun; 87(12):4949-58. PubMed ID: 8652807
[TBL] [Abstract][Full Text] [Related]
10. p16INK4 and p15INK4B alterations in primary gynecologic malignancy.
Wong YF; Chung TK; Cheung TH; Nobori T; Yim SF; Lai KW; Phil M; Yu AL; Diccianni MB; Li TZ; Chang AM
Gynecol Oncol; 1997 May; 65(2):319-24. PubMed ID: 9159345
[TBL] [Abstract][Full Text] [Related]
11. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors.
Zariwala M; Xiong Y
Oncogene; 1996 Nov; 13(9):2033-8. PubMed ID: 8934552
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of the cyclin-dependent kinase inhibitor genes p15INK4b/MTS2, p16INK4/MTS1, p18 and p19 in human cancer cell lines.
Gemma A; Takenoshita S; Hagiwara K; Okamoto A; Spillare EA; McMemamin MG; Hussain SP; Forrester K; Zariwala M; Xiong Y; Harris CC
Int J Cancer; 1996 Nov; 68(5):605-11. PubMed ID: 8938142
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
Herman JG; Jen J; Merlo A; Baylin SB
Cancer Res; 1996 Feb; 56(4):722-7. PubMed ID: 8631003
[TBL] [Abstract][Full Text] [Related]
14. [Inhibitors of cyclins/CDK of the 9p21 chromosomal region and malignant hemopathies].
Quesnel B
Bull Cancer; 1998 Sep; 85(9):747-54. PubMed ID: 9817058
[TBL] [Abstract][Full Text] [Related]
15. High-risk myelodysplastic syndromes and hypermethylation of the p15Ink4B gene.
Uchida T; Kinoshita T; Hotta T; Murate T
Leuk Lymphoma; 1998 Dec; 32(1-2):9-18. PubMed ID: 10036997
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of the cell cycle inhibitor p15INK4b 3'-untranslated region interferes with its transcriptional regulation in primary lymphomas.
Malumbres M; Pérez de Castro I; Santos J; Fernández Piqueras J; Pellicer A
Oncogene; 1999 Jan; 18(2):385-96. PubMed ID: 9927195
[TBL] [Abstract][Full Text] [Related]
17. Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-alpha and p16INK4a-beta in mouse lung tumor cells.
Herzog CR; Soloff EV; McDoniels AL; Tyson FL; Malkinson AM; Haugen-Strano A; Wiseman RW; Anderson MW; You M
Oncogene; 1996 Nov; 13(9):1885-91. PubMed ID: 8934534
[TBL] [Abstract][Full Text] [Related]
18. Exclusive p15INK4B gene deletions in acute lymphocytic leukemia include the E1 beta exon of the p16INK4 gene.
Heyman M; Rasool O; Brandter LB; Liu Y; Grandér D; Einhorn S; Söderhäll S
Blood; 1996 Feb; 87(4):1657-8. PubMed ID: 8608263
[No Abstract] [Full Text] [Related]
19. Role of the cyclin-dependent kinase 4 and 6 inhibitor gene family p15, p16, p18 and p19 in leukemia and lymphoma.
Siebert R; Willers CP; Opalka B
Leuk Lymphoma; 1996 Nov; 23(5-6):505-20. PubMed ID: 9031081
[TBL] [Abstract][Full Text] [Related]
20. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies.
Herman JG; Civin CI; Issa JP; Collector MI; Sharkis SJ; Baylin SB
Cancer Res; 1997 Mar; 57(5):837-41. PubMed ID: 9041182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]